Real-time enrollment status for this recurrent renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:30 AM UTC
| NCT Number | NCT05641935 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Renal Cell Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 210 participants |
| Active Locations | 1 sites in the US |
| Sponsor | john eisenbrey |
| Last Updated on CT.gov | February 17, 2026 (Feb 17, 2026) |
As of July 17, 2026: Clinical trial NCT05641935 is currently recruiting participants. This phase2 study for recurrent renal cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by john eisenbrey. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05641935 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05641935 was last updated Feb 17, 2026 (February 17, 2026). HelloStudys verifies this status automatically.